Drug Side Effects
Search
TRANSITIONAL CELL CARCINOMA RECURRENT
TRANSITIONAL CELL CARCINOMA RECURRENT
was reported 58 times
TRANSITIONAL CELL CARCINOMA RECURRENT is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]
3
0.0017
1
Erythroid Maturation Agent [EPC]
1
0.0004
2
Programmed Death Receptor-1 Blocking Antibody [EPC]
23
0.0002
3
CD38-directed Cytolytic Antibody [EPC]
1
0.0002
4
Platinum-based Drug [EPC]
15
0.0001
5
Programmed Death Ligand-1 Blocker [EPC]
1
0.0000
6
Microtubule Inhibitor [EPC]
6
0.0000
7
Interleukin-12 Antagonist [EPC]
3
0.0000
8
Interleukin-23 Antagonist [EPC]
3
0.0000
9
Leukocyte Growth Factor [EPC]
3
0.0000
10
Janus Kinase Inhibitor [EPC]
3
0.0000
11
BCL-2 Inhibitor [EPC]
1
0.0000
12
Integrin Receptor Antagonist [EPC]
1
0.0000
13
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
14
5-alpha Reductase Inhibitor [EPC]
1
0.0000
15
Thalidomide Analog [EPC]
5
0.0000
16
CD20-directed Cytolytic Antibody [EPC]
3
0.0000
17
Antirheumatic Agent [EPC]
1
0.0000
18
Proteasome Inhibitor [EPC]
1
0.0000
19
Alkylating Drug [EPC]
2
0.0000
20
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
21
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
22
Calcium [EPC]
1
0.0000
23
Vitamin D [EPC]
1
0.0000
24
Corticosteroid [EPC]
4
0.0000
25
Vitamin B12 [EPC]
1
0.0000
26
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
27
Vitamin C [EPC]
1
0.0000
28
Kinase Inhibitor [EPC]
1
0.0000
29
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000